The largest database of trusted experimental protocols

Tlr3 ligand poly 1 c

Manufactured by InvivoGen
Sourced in United States

TLR3 ligand poly (I:C) is a laboratory product designed to activate the Toll-like receptor 3 (TLR3) signaling pathway. It is a synthetic double-stranded RNA (dsRNA) molecule that mimics the structure of viral RNA, triggering an immune response. The core function of this product is to serve as a tool for research purposes, facilitating the study of TLR3-mediated signaling and its implications in various biological processes.

Automatically generated - may contain errors

8 protocols using tlr3 ligand poly 1 c

1

TLR3-Mediated Inflammatory Response in Chicken Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly (I:C) (TLR3 ligand) was purchased from InVivogen (San Diego, CA, USA) and dissolved in endotoxin and nuclease free water and kept at −20°C until use. DF-1 cells were treated at the concentrations of 0.1, 1, 5, and 10 μg/mL for 24 h. Also, to determine the time kinetics of mRNA expression, cells were treated for 1, 3, 6, 12, and 24 h at 10 μg/mL concentration. BAY 11–7085 and Tanshione IIA were purchased from Sigma-Aldrich (Louis, MO, USA). BAY 11-7085 (BAY) inhibits the IκBα phosphorylation, resulting in prevention of NFκB activation, was used as NFκB inhibitor. Tanshinone IIA (Tan-II) may inhibit the binding of AP-1 to DNA in chicken heteophils [19 (link)]. DF-1 cells were pretreated with BAY 11–7085 (5 μM) and Tan-II (25 μM), for 3 h, of which concentrations and time were determined from the preliminary experiment in this study, and then stimulated with poly (I:C) (5 μg/mL) for 3 h.
+ Open protocol
+ Expand
2

Heat-Inactivated Viral Antigen Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heat-inactivated Influenza B Brisbane (7,4*10x3 K/mL TCID50), heat-inactivated Influenza H1N1 California (3,24 x 10x5 K/mL TCID50), and heat-inactivated SARS-CoV-2 Wuhan-Hu-1 variant (1,4 x 10x3K/mL TCID50) were used in the study. Viruses had been heat-inactivated for 30 minutes at 60°C. Heat-inactivation had been checked for sufficiency by cell culture inoculation and subsequent qPCR testing. R848 (Resiquimod, TLR7/8 ligand) (Invivogen, San Diego, CA, USA) (3 μg/mL); Poly I:C (TLR3 ligand) (Invivogen, San Diego, CA, USA) (10 μg/mL).
+ Open protocol
+ Expand
3

Inactivated H9N2 AIVs Vaccine Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9N2 AIVs (A/Chicken/Jiangsu/DHN12/2013 (H9N2, HA clade: 4.2.5)) was obtained from the Guangdong Enterprise Key Laboratory of Biotechnology R&D of Veterinary Biologics. Briefly, the H9N2 vaccine candidate virus (50% egg infective dose, EID50 at 108/0.1 mL) was propagated in 10-day-old embryonated SPF chicken eggs (Guangdong Enterprise Key Laboratory of Biotechnology R&D of Veterinary Biologics). Virus titers were measured following the method of Reed & Muench as described previously [6 (link),21 (link)]. Virulent H9N2 AIVs was inactivated with 0.05% formaldehyde (Ferak Berlin Gmbh, Berlin, Germany) by incubating at 4°C for 12 h. Complete inactivation of the virus was confirmed through repeated passages in 10-day-old embryonated SPF chicken eggs and Madin-Darby canine kidney cells as previously described [6 (link),21 (link)]. The inactivated H9N2 AIVs antigen (H9N2 IAIV) was purified on a discontinuous sucrose density gradient as described [22 (link)].
The 1-day-old white Muscovy (Wens Foodstuff Group, China) was raised in an isolator to allow the animals to eat and drink normally. These ducks were raised for two weeks to adapt to their living environment. All duck serum samples were confirmed to be free of any AIV infection in the study. Adjuvant of TLR2 ligand pam2CSK4, TLR3 ligand poly (I:C) and TLR7 ligand imiquimod were purchased from InvivoGen (San Diego, CA).
+ Open protocol
+ Expand
4

PBMC and DC Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated NK cells or total PBMCs were cultured in medium only (negative control) or with 10 ng/mL IL-15 (Miltenyi) for 24 hours. When indicated, BCL2 inhibitor Venetoclax (Selleckchem) was added at a concentration of 100nM. Isolated mDCs were cultured in medium only (negative control) or with 2 μg/mL TLR3 ligand Poly(I:C) (Invivogen) for 24 hours. K562 were cultured in medium only for expansion. The cells were cultured in RPMI medium (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS) (MilliporeSigma), 1% l-glutamine (Corning), 1% penicillin/streptomycin (Corning), and 1% HEPES buffer (Corning) and kept at 37°C in 5% CO2 during the culture.
+ Open protocol
+ Expand
5

Recombinant Cytokine Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant murine FLT3L was purchased from eBioscience (San Diego, CA). Recombinant murine GM-CSF, murine IL4, murine and human IL17A was purchased from R&D Systems (Minneapolis, MN). TLR4 ligand lipopolysaccharide LPS and TLR3 ligand poly (I:C) were purchased from InvivoGen (San Diego, CA).
+ Open protocol
+ Expand
6

Signaling Pathways Activated by TLR Ligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
TLR2 ligand Pam3CSK4, TLR3 ligand Poly(I:C), TLR4 ligand LPS, TLR7/8 ligand CL087, TLR9 ligand CpG ODN, p38 inhibitor SB2021980, and ERK1/2 inhibitor U0126 were purchased from InvivoGen (San Diego, CA, USA). High-mobility group box 1 protein (HMGB1) was from Sigma-Aldrich (St. Louis, MO, USA). Kinases inhibitors including SB203580, PD98059, SP600125, and LY294002 were purchased from Calbiochem (San Diego, CA, USA); and antibodies against p38, phospho-p38, ERK1/2, phospho-ERK1/2, Akt, phospho-Akt (Ser473), JNK1/2, phospho-JNK1/2, CREB, phospho-CREB, NF-κB, and phospho-NF-κB were obtained from Cell Signaling (Danvers, MA, USA).
+ Open protocol
+ Expand
7

Lipid-mediated Nucleic Acid Delivery Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOPC lipid and CF-lipid were purchased from Avanti Polar Lipids as solutions in chloroform. TLR9 ligand ODN sequences, negative control sequences, and their dye-labeled modification sequences (Table S1) were synthesized on an ABI 3900 DNA oligo synthesizer with reagents purchased from Glen Research. TLR3 ligand poly(I:C) was purchased from InvivoGen. Cy3-labeled poly(I:C) was prepared using Label IT Nucleic Acid Labeling Kits (Mirus Bio) following the manufacturer’s protocol. The cell-culture medium was prepared using RPMI 1640-GlutaMAX (Gibco) supplemented with heat-inactivated fetal bovine serum (10%, Atlanta Biologicals, processed by shaking at 100 rpm at 56 °C for 30 min on a temperature-controlled shaker), penicillin-streptomycin (100 U mL−1, Gibco), and sodium pyruvate (1 mM, Gibco).
+ Open protocol
+ Expand
8

Profiling lncRNA Expression in Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human monocytic cell lines, THP-1 cells (ATCC TIB-202; American Type Culture Collection, Rockville, Md.), were grown in lipopolysaccharide (LPS)-free RPMI medium (Gibco, ThermoFisher Scientific, USA) supplemented with 10% fetal bovine serum in an incubator containing 5% CO 2 at 37°C. One million cells cultured in LPS-free RPMI medium were treated with TLR3 ligand poly(I:C) (Invivo-Gen, California, USA) or TLR4 ligand LPS (Sigma-Aldrich, Merk, Darmstat, Germany) for 4 hours and 24 hours respectively. PBMCs derived from healthy controls were rested overnight in RPMI medium at 37°C incubator, and were separated into the adherent monocytes and the suspended lymphocytes. Poly(I:C) and LPS stimulation experiments were also performed on primary monocytes and lymphocytes. RNAs were then extracted from THP-1 cells, primary human monocytes and lymphocytes for further qRT-PCR analyses. The difference in expression of the target gene relative to averaged internal control gene was calculated using the comparative threshold cycle (Ct) method and evaluated by ΔCT (CT lncRNA -CT GAPDH ). The fold of expression of lncRNAs was calculated by 2^-ΔΔCT [(CT lncRNA -CT GAPDH ) -median ΔCT of control replicates].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!